United Health Products Inc (PK:UEEC)

Mar 21, 2024 08:37 am ET
United Health Products Submits Full FDA PMA Application
via NewMediaWire -- United Health Products, Inc. (OTCPK: UEEC) today provided an update on the company’s FDA Premarket Approval application process.   The company confirms that it has submitted via the FDA eSTAR portal its Premarket Approval...
Jan 19, 2024 08:32 am ET
United Health Products Reports on FDA Application Status
via NewMediaWire – United Health Products (UEEC) reports today on the receipt and review of final reports on product sterilization and stability testing for its hemostatic gauze. As previously disclosed, UHP has been working with external packaging...
Oct 03, 2023 04:30 pm ET
United Health Products Reports on FDA Application Status
via NewMediaWire - United Health Products, Inc. (OTCPK: UEEC) today provided an update on the company’s FDA Premarket Approval application process.   The company reports today that the packaging testing process is substantially completed...
Aug 04, 2023 08:29 am ET
United Health Products Reports on Product Testing for FDA Application
via NewMediaWire – United Health Products, Inc. (OTCPK: UEEC) today provided an update on the company’s FDA Premarket Approval application process.   Due to further unanticipated delays in testing performed by external service providers, the...
Jun 27, 2023 05:06 pm ET
United Health Products Reports on Progress in Product Testing
via NewMediaWire – United Health Products, Inc. (OTCPK: UEEC) today provided an update on the company’s FDA Premarket Approval application process.  As previously disclosed, UHP is conducting FDA required testing on its packaged products in...
Jun 07, 2023 04:34 pm ET
United Health Products Reiterates Guidance on FDA PMA Application Process
via NewMediaWire – United Health Products, Inc. (OTCPK: UEEC) today provided an update on the company’s FDA Premarket Approval application process.  As disclosed in a press release on March 29, 2023, UHP has produced additional batches of its...
Mar 29, 2023 08:48 am ET
United Health Products Provides Update on FDA PMA Application Process
via NewMediaWire – United Health Products, Inc. (OTCPK: UEEC) today provided an update on the company’s FDA Premarket Approval application process.   As disclosed in a press release on January 31, 2023, UHP produced three batch lots of its...
Jan 31, 2023 09:00 am ET
United Health Products Provides Update on FDA PMA Application and Amendment to White Lion Agreement
via NewMediaWire -- United Health Products, Inc. (OTCPK: UEEC), (UHP) today provided an update on the company’s FDA Premarket Approval application process and the amendment of its Agreement with White Lion Capital.   UHP continues to advance its...
Dec 19, 2022 08:30 am ET
United Health Products Provides Update on Manufacturing and FDA PMA Application
via NewMediaWire – United Health Products, Inc. (OTCPK: UEEC), (UHP) today provided an update on the company’s FDA Premarket Approval application. UHP continues to advance its Premarket Approval application with the Food and Drug Administration....
Nov 28, 2022 08:46 am ET
United Health Products Provides Update on FDA PMA Application
via NewMediaWire -- United Health Products, Inc. (OTCPK: UEEC), (UHP) today provides an update on the company’s FDA Premarket Approval application.   UHP continues to advance its Premarket Approval application with the Food and Drug...
Oct 31, 2022 09:00 am ET
United Health Products Provides Update on FDA PMA Application
via NewMediaWire -- United Health Products, Inc. (OTCPK: UEEC), (UHP) today provided an update on the company’s FDA Premarket Approval application and financial reporting calendar.   As previously disclosed in its press release of September...
Sep 06, 2022 10:11 am ET
United Health Products Announces Equity Financing Agreement and Provides Corporate Update
via NewMediaWire -- United Health Products, Inc. (OTCPK: UEEC), (UHP) today announced that it has entered into a common stock purchase agreement to sell up to $10 million of shares to White Lion Capital, LLC (White Lion), a California-based...
Jun 16, 2022 02:48 pm ET
United Health Products Announces Settlement of SEC Investigation
via NewMediaWire – United Health Products, Inc. (OTCPK: UEEC) (UHP), today announced a final settlement of the SEC investigation initially reported by the Company in its Annual Report on Form 10-K for the year ended December 31, 2021.   UHP has...
May 18, 2022 10:34 am ET
United Health Products Provides Regulatory Update
via NewMediaWire -- United Health Products, Inc. (OTCPK: UEEC), (UHP) today provided an update on its FDA regulatory process.   Regulatory ReviewAs previously disclosed, on April 20, 2022, UHP delivered to the U.S. Food & Drug Administration...
Apr 27, 2022 09:38 am ET
United Health Products Provides Regulatory and Business Update
via NewMediaWire -- United Health Products, Inc. (OTCPK: UEEC), (UHP) today provided an update on its FDA regulatory process and other matters.   Regulatory Review As previously disclosed in the company’s Form 10-K, the U.S. Food & Drug...
Oct 07, 2021 07:00 am ET
United Health Products Provides Business Update
United Health Products, Inc. (OTCPK: UEEC), (UHP), developer, manufacturer and marketer of HemoStyp™, a patented Neutralized Oxidized Regenerated Cellulose (NORC) hemostatic agent, today provided an update on its regulatory approval application...
Jun 28, 2021 03:30 pm ET
United Health Products Provides Corporate Update and Announces Equity Financing
HENDERSON, NV / ACCESSWIRE / June 28, 2021 / United Health Products, Inc. (OTCPK:UEEC), ('UHP'), developer, manufacturer and marketer of HemoStyp, a patented Neutralized Oxidized Regenerated Cellulose hemostatic agent, today provided a corporate update on its current product development and commercialization activities.
May 05, 2021 08:10 am ET
United Health Products’ HemoStyp® Gauze Advances to FDA Substantive Review
United Health Products, Inc. (OTCPK: UEEC), (“UHP” or the “Company”), developer, manufacturer and marketer of HemoStyp®, a patented Neutralized Oxidized Regenerated Cellulose hemostatic agent, received notification this week from the Food & Drug Administration (FDA) that, following the resubmission of its application for Pre-market Approval for HemoStyp gauze on April 6th, the FDA has now accepted for review and commenced its Substantive Review of the application.
Feb 17, 2021 08:00 am ET
United Health Products Obtains International Patent Protection Measures for HemoStyp® Hydrocolloid
United Health Products, Inc. (OTC: UEEC), (“UHP” or the “Company”), developer of HemoStyp, a patented Neutralized Oxidized Regenerated Cellulose (NORC) hemostatic agent, today announced the publication under the Patent Cooperation Treaty of its international patent application relating to any hydrocolloid format of HemoStyp.
Nov 24, 2020 08:05 am ET
United Health Products Announces Leadership Changes
United Health Products, Inc. (OTC: UEEC), (“UHP” or the "company”), developer, manufacturer and marketer of HemoStyp®, a patented Neutralized Oxidized Regenerated Cellulose (NORC) hemostatic agent, today announced changes to its senior management team and its Board of Directors.
Jul 21, 2020 08:00 am ET
United Health Products Files HemoStyp® Hydrocolloid Patents
United Health Products, Inc. (OTC: UEEC) (“UHP” or the “Company”), today announced that it has filed a non-provisional patent application with the U.S. Patent & Trademark Office for the hydrocolloid (gel) format of its HemoStyp oxidized regenerated cellulose product, and has also filed a separate application under the Patent Cooperation Treaty with the World Intellectual Property Organization. The Patent Cooperation Treaty (PCT) is an international patent law treaty which provides a unified procedure for filing of a patent application in the majority of foreign countries. The Company previousl
May 07, 2020 02:27 pm ET
United Health Products Announces FDA Update Post-Dialysis Patch Product Developed
United Health Products, Inc. (OTC: UEEC), (“UHP” or the “company”), manufacturer and marketer of HemoStyp®, an Oxidized Regenerated Cellulose that is patented through Oct 2029 (US Patent 8,557,874 Oct 15,2013) for the healthcare and wound care sectors, today announced that is has recently received correspondence from the FDA regarding its current PMA class III submission for use in surgical applications . The company continues to coordinate and respond to FDA information requests in a timely manner.
Mar 20, 2020 09:00 am ET
United Health Products Issues Progress Report
United Health Products, Inc. (OTC: UEEC) (UHP or the company) today announced that it is proceeding with its Premarket Approval (PMA) application for Class III approval to the FDA for HemoStyp®. In this current difficult environment, UHP has been working continuously with the FDA to advance its application, and has been working towards commercialization in anticipation of FDA approval.
Nov 06, 2019 12:35 pm ET
United Health Products Reschedules Corporate Update Call
United Health Products, Inc. (OTC: UEEC) is rescheduling its corporate update conference call conference to Thursday November 7, 2019 at 4:30 pm Eastern Time; the call was originally scheduled for 11 am Eastern Time on the same date. Douglas...
Nov 04, 2019 12:23 pm ET
United Health Products to Host Corporate Update Call
United Health Products, Inc. (OTC: UEEC) will host a corporate update conference call on Thursday, November 7, 2019 at 11:00 am Eastern Time. Douglas Beplate, CEO, and Louis Schiliro, COO, will give the update. There will be no Q&A. To listen to...
Oct 23, 2019 03:02 pm ET
HemoStyp® Human Trial Results Journal Article to be Submitted for Peer Review
United Health Products, Inc. (OTC: UEEC), (“UHP”), developer, manufacturer and marketer of HemoStyp, an Oxidized Regenerated Cellulose, today announced that four surgeons who participated in the recently completed human clinical trial for HemoStyp...
Oct 18, 2019 07:00 am ET
United Health Products Announces Positive Results from HemoStyp® Human Clinical Trial
United Health Products, Inc. (OTC: UEEC), (“UHP” or the “Company”), manufacturer and marketer of HemoStyp®, an Oxidized Regenerated Cellulose that is patented through Oct 2029 (US Patent 8,557,874 Oct 15, 2013), for the healthcare and wound care...
Oct 17, 2019 11:06 am ET
United Health Products to Move Manufacturing to U.S.
United Health Products, Inc. (OTC: UEEC), (“UHP” or the “Company”), developer, manufacturer and marketer of HemoStyp®, an Oxidized Regenerated Cellulose gauze, today announced that it will relocate the majority of its manufacturing operations to a...
Oct 08, 2019 06:25 pm ET
United Health Products Files Defamation Lawsuit Against Short Sellers
United Health Products, Inc. (OTC: UEEC), (“UHP” or the “Company”), manufacturer and marketer of HemoStyp®, an Oxidized Regenerated Cellulose, today announced it has filed a defamation, trade libel and unlawful and deceptive practices lawsuit...
Oct 04, 2019 07:00 am ET
United Health Products Announces Submission of Premarket Approval (PMA) Application to the U.S. FDA for the HemoStyp® Device for Use in Surgical Procedures
United Health Products, Inc. (UHP) (OTC: UEEC) today announced that it has submitted a Premarket Approval (PMA) application for Class III approval to the FDA for HemoStyp. The PMA program confirms the safety and efficacy of a product. If...
Sep 06, 2019 02:57 pm ET
United Health Products Appoints Dr. Gerard Abate Chief Medical Director
United Health Products, Inc. (OTC: UEEC), (“UHP” or the “Company”), manufacturer and marketer of HemoStyp, a patented hemostatic gauze for the healthcare and wound care sectors, today announced that it has appointed Dr. Gerry Abate, MD as Chief...
Aug 29, 2019 02:27 pm ET
Recent Publicity About United Health Products
United Health Products, Inc. (OTC: UEEC), (“UHP” or the “Company”), manufacturer and marketer of HemoStyp®, an Oxidized Regenerated Cellulose, today announced that over the past 2 ½ weeks articles have been published about UHP, without UHP’s review...
Aug 28, 2019 10:58 am ET
Corrected News Release - United Health Products Announces Completion of Human Trial Study
United Health Products, Inc. (OTC: UEEC), (“UHP” or the “Company”), manufacturer and marketer of HemoStyp®, an Oxidized Regenerated Cellulose that is patented through Oct 2029 (US Patent 8,557,874 October 15, 2013), for the healthcare and wound...
Aug 28, 2019 08:00 am ET
United Health Products Announces Completion of Human Trial Study
United Health Products, Inc. (OTC: UEEC), (“UHP” or the “Company”), manufacturer and marketer of HemoStyp®, an Oxidized Regenerated Cellulose that is patented through Oct 2029 (US Patent 8,857,874 Oct 2015), for the healthcare and wound care...
Aug 14, 2019 12:45 pm ET
United Health Products Announces Completion of Pathology and Study of Preclinical Bone Application of HemoStyp®
United Health Products, Inc. (OTC: UEEC), (“UHP” or the “Company”), manufacturer and marketer of HemoStyp, a patented hemostatic gauze for the healthcare and wound care sectors, today announced that it had received the pathology results of a...
Aug 08, 2019 09:00 am ET
United Health Products Files New Patent Application Method of Forming and Using a Hemostatic Hydrocolloid
United Health Products, Inc. (OTC: UEEC), (“UHP” or the “Company”), manufacturer and marketer of HemoStyp®, today announced that it has filed a patent application covering methods of forming and using a hemostatic material, and more specifically,...
Aug 05, 2019 03:54 pm ET
United Health Products Announces the Completion of Human Trial Surgery Enrollment
United Health Products, Inc. (OTC: UEEC), (“UHP” or the “Company”), manufacturer and marketer of HemoStyp®, a patented hemostatic gauze for the healthcare and wound care sectors, announces that it has successfully completed the surgeries for its...
Jul 09, 2019 09:00 am ET
United Health Products Issues Shareholder Update
United Health Products, Inc. (OTC: UEEC), (“UHP” or the “Company”), manufacturer and marketer of HemoStyp®, a patented hemostatic gauze for the healthcare and wound care sectors, today announced updates on: Human Clinical Trial HemoStyp is under...
May 07, 2019 08:00 am ET
United Health Products Announces Completion of IQVIA Independent Market Assessment for HemoStyp® in Support of Review of Strategic Alternatives
United Health Products, Inc. (OTC: UEEC), (“UHP” or the “Company”), manufacturer and marketer of HemoStyp, a patented hemostatic gauze for the healthcare and wound care sectors, today announced that IQVIA has completed its independent market...
Apr 24, 2019 08:00 am ET
United Health Products Retains IQVIA to Conduct U.S. Market Commercialization Study of HemoStyp® in Support of Société Générale’s Strategic Review
United Health Products, Inc. (OTC: UEEC), (“UHP” or “the company”), manufacturer and marketer of HemoStyp®, a patented hemostatic gauze for the healthcare and wound care sectors, today announced that it had retained IQVIA Inc. to conduct a U.S....
Apr 02, 2019 08:00 am ET
United Health Products Announces 2018 Results
United Health Products, Inc. (OTC: UEEC) (“UHP” or the “Company”), manufacturer and marketer of HemoStyp®, a patented hemostatic gauze for the healthcare and wound care sectors, today filed its Form 10-K for the year ended December 31, 2018. The...
Dec 17, 2018 01:37 pm ET
United Health Products to Hold Conference Call on December 20, 2018 to Discuss Recent Corporate Developments and Provide Year End Update
United Health Products, Inc. (OTC: UEEC), (“UHP” or the “Company”), a manufacturer and marketer of HemoStyp®, a patented hemostatic gauze for the healthcare and wound care sectors, today announced that it will hold a dial-in conference call for...
Nov 02, 2018 09:00 am ET
United Health Products Retains Legal Counsel Ruskin Moscou Faltischek P.C to Assist in Strategic Review
United Health Products, Inc. (OTC: UEEC), (“UHP” or the “Company”), manufacturer and marketer of HemoStyp®, a patented hemostatic gauze for the healthcare and wound care sectors, today announced that it had retained Ruskin Moscou Faltischek P.C. to...
Oct 25, 2018 08:30 am ET
United Health Products Engages Société Générale to Undertake Strategic Review
United Health Products, Inc. (OTC: UEEC), (“UHP” or the “Company”), manufacturer and marketer of HemoStyp®, a patented hemostatic gauze for the healthcare and wound care sectors, today announced the following corporate developments: Review of...
Aug 08, 2018 06:00 am ET
United Health Products’ HemoStyp® to Begin Human Trials
United Health Products, Inc. (UHP) (OTC: UEEC), manufacturer and marketer of HemoStyp, a patented hemostatic gauze for the healthcare and wound care sectors, today announced that its protocol submission for human testing has been reviewed by the...
Jul 09, 2018 09:00 am ET
United Health Products to Offer Retail Sales of HemoStyp® Products on Walmart.com and Jet.com
United Health Products, Inc. (OTC:UEEC), manufacturer and marketer of HemoStyp, a patented hemostatic gauze for the healthcare and wound care sectors, today announced that it has been accepted as a Walmart.com and Jet.com supplier, and will offer...
Jun 19, 2018 09:00 am ET
United Health Products Files IDE Pre-Submission with the FDA for Approval to Begin Human Trials of HemoStyp®
United Health Products, Inc. (UHP) (OTC:UEEC), manufacturer and marketer of HemoStyp, a patented hemostatic gauze for the healthcare and wound care sectors, today announced that after successfully completing a series of animal tests, it has filed...
May 01, 2018 09:00 am ET
United Health Products Expands Animal Testing for HemoStyp® in Support of PMA Application, Human Trials to Follow
HENDERSON, Nev., May 01, 2018 (GLOBE NEWSWIRE) -- United Health Products, Inc. (UHP) (OTC:UEEC), manufacturer and marketer of HemoStyp, a patented hemostatic gauze for the healthcare and wound care sectors, today announced that it is launching expanded and more...
Mar 19, 2018 08:30 am ET
United Health Products Forms Medical Advisory Board
HENDERSON, Nev., March 19, 2018 (GLOBE NEWSWIRE) -- United Health Products, Inc. (UHP) (OTC:UEEC), manufacturer and marketer of HemoStyp®, a patented hemostatic gauze for the healthcare and wound care sectors, is pleased to announce the formation of a Medical...
Mar 13, 2018 05:30 am ET
United Health Products Receives CE Mark Approval for HemoStyp®
Product Now Approved for Use in European Economic Area
Feb 05, 2018 09:00 am ET
United Health Products Announces Completion of FDA PMA for HemoStyp®
HENDERSON, Nev., Feb. 05, 2018 (GLOBE NEWSWIRE) -- United Health Products, Inc. (UHP) (OTC:UEEC) today announced that, following its January 17 face-to- face meeting with FDA experts and officials, it has  completed and submitted all materials relevant for...
Jan 30, 2018 08:30 am ET
United Health Products Issues Update on HemoStyp®South Korea MFDS Application
HENDERSON, Nev., Jan. 30, 2018 (GLOBE NEWSWIRE) -- United Health Products, Inc. (UHP) (OTC:UEEC), manufacturer and marketer of HemoStyp, a patented hemostatic gauze for the healthcare and wound care sectors, today announced that Quantum Health Group, one of its...
Jan 22, 2018 08:15 am ET
United Health Products Issues FDA Update
HENDERSON, Nev., Jan. 22, 2018 (GLOBE NEWSWIRE) -- United Health Products, Inc. (UHP) (OTCPK:UEEC), manufacturer and marketer of HemoStyp®, a patented hemostatic gauze for the healthcare and wound care sectors, today announced that, following a face-to-face meeting between FDA...
Jan 09, 2018 08:05 am ET
United Health Products Gains Patent Protection Extension for HemoStyp®
Obtains Key Patent Protection for HemoStyp until 2029
Dec 18, 2017 08:30 am ET
Dec 12, 2017 09:42 am ET
United Health Products Applying for Class III Designation for HemoSytp® by Australian TGA
HENDERSON, Nev., Dec. 12, 2017 (GLOBE NEWSWIRE) -- United Health Products, Inc. (UHP) (OTC:UEEC), manufacturer and marketer of HemoStyp®, a patented hemostatic gauze for the healthcare and wound care sectors, today announced it is applying to have HemoStyp designated...
Dec 04, 2017 08:30 am ET
FDA Selects HemoStyp® for CtQ Pilot Program
HENDERSON, Nev., Dec. 04, 2017 (GLOBE NEWSWIRE) -- United Health Products, Inc. (UHP) (OTC:UEEC), manufacturer and marketer of HemoStyp®, a patented hemostatic gauze for the healthcare and wound care sectors, today announced it is proceeding with its application...
Nov 29, 2017 06:00 am ET
United Health Products Announces Medical Device Approval for HemoStyp® in South African Market
United Health South African Distributor SSEM Mthembu Medical Commences Marketing
Nov 09, 2017 12:59 pm ET
United Health Products Inc. Announces Hemostyp® as featured product of Dick’s Sporting Goods Advanced Wound Care Kit
HENDERSON, Nev., Nov. 09, 2017 (GLOBE NEWSWIRE) -- United Health Products, Inc. (OTCQB:UEEC) announced that their 2’ x 4” trauma gauze product has been selected as the feature component for a new Advanced Wound care kit for Dick’s...
Oct 10, 2017 08:15 am ET
United Health Products Issues FDA Submission Update
HENDERSON, Nev., Oct. 10, 2017 (GLOBE NEWSWIRE) -- United Health Products, Inc. (OTC:UEEC), a manufacturer and marketer of HemoStyp®, a patented hemostatic gauze for the healthcare and wound care sectors, today announced that its current Expanded Indication Submission Class II application for HemoStyp for internal usage with the U.S. FDA continues to progress, and is in an advanced stage of review.  In addition, the company is pleased to announce that it has applied to the FDA’s new and innovative CtQ Pilot Program premarket approval PMA (Class III internal usage) for HemoStyp....
Apr 18, 2017 03:19 pm ET
United Health Products Inc. to file late 2016 audited year end
United Health Products, Inc. (OTCQB: UEEC) announced that revenues for the fourth quarter of 2016 were approximately $252,000 and we expect to see increasing quarterly revenues for 2017. Our independent registered public accountants, Pritchett Siler & Hardy, P.C., are in the process of auditing our 2016 financial statements and will present to the prior auditors RRBB for their opinion and approval. A late filing of our Form 10-K for the fiscal year ended December 31, 2016 is anticipated within the next two weeks. Douglas Beplate, CEO of UHP, commented that this is a major step forward for
Mar 31, 2017 11:03 am ET
United Health Products Inc. To Host Dial in Corporate Update
United Health Products, Inc. (OTCQB: UEEC) will hold a dial in conference for shareholders, potential shareholders and those seeking to learn more about the company on Tuesday, April 4, 2017 at 12:30 p.m Eastern Time. Douglas Beplate CEO and Louis Schiliro Director of Manufacturing will discuss present business, marketing plans for 2017 and future events for 2017. To listen to the discussion:
Jan 12, 2017 11:20 am ET
UNITED HEALTH PRODUCTS INC. To Host Dial in Corporate Update
United Health Products, Inc. (OTCQB: UEEC) will hold a dial in conference for shareholders, potential shareholders and those seeking to learn more about the company on Tuesday 17, 2017 at 12:30 p.m Eastern Time. Douglas Beplate CEO and Louis Schiliro Director of Manufacturing will discuss year end 2016, present business, and current rollout to the veterinary market, marketing plans for 2017 and future events for 2017. To listen to the discussion:
Nov 17, 2016 08:30 am ET
United Health Products Inc. Announces Exclusive Distribution Agreement for South Korea and Dial in Business Update
United Health Products Inc. (OTCQB: UEEC) announced that it has granted Carney Export - Import the exclusive rights to distribute United Health Products Inc. HemoStyp® products to all markets in South Korea. Carney Export - Import's South Korean operations will be under the direction of David Champion. Mr. Champion is a former Marketing Director of Covidien, and a former Product Manager of Tyco for the Asian markets.
Oct 11, 2016 09:00 am ET
United Health Products Inc. to Host Dial-In Corporate Update
United Health Products Inc. (OTCQB: UEEC) will hold a dial-in conference for shareholders, potential shareholders and those seeking to learn more about the company on October 13, 2016. Douglas Beplate, CEO, and Louis Schiliro, Director of Manufacturing, will discuss the company's current events and expansion of manufacturing capacities to meet the increase in current orders in the dental, veterinary, medical and retail markets. Management will also report on the future plans and efforts of the company to uplist to a higher exchange. The call-in conference will be Thursday, October 13th at
May 16, 2016 01:00 pm ET
United Health Products Inc. Announces Optimal Government Services Has Completed Their Distribution Agreement and Placed Stocking Orders
United Health Products Inc. (OTCQB: UEEC) announced that Optimal Government Resources has signed their distribution agreement and placed an opening stocking order. In conjunction with this agreement, UHP HemoStyp® products are now listed under the DAPA contract # SP0200-09-H-0037. This begins an exciting new chapter for United Health Products and allows all US military, US government agencies and VA systems to order directly or via their Prime Vendor agreements.
May 03, 2016 09:00 am ET
United Health Products Announces Henry Schien Halas as Exclusive Distributor
United Health Products, Inc. (OTCQB: UEEC) announced that they have signed Henry Schein Halas to an exclusive distribution agreement for all of United Health's HemoStyp® products in conjunction with an initial stocking order for Australia and the African Continent. Henry Schein Halas was formed in 2006, when two of Australia's most innovative and successful dental businesses joined together. Built on decades of service to the profession by Halas Dental Ltd and Henry Schein Regional Ltd, the company maintains strong Australian management together with the commitment and investment of
Mar 18, 2016 09:00 am ET
REMINDER: United Health Products Inc. Announces Total Resources International as Specialty - Retail Distributor
United Health Products, Inc. (OTCQB: UEEC) announced that it has entered into a 5 year contract with Total Resources International (TRI) as a United States Specialty and Retail Distributor. The contract guarantees minimum purchases of United Health Products Inc.'s HemoStyp® products with yearly increases over the previous year. The contract calls for 150,000 trauma pads, 500,000 boxes of HemoStrips® and an exclusive distribution of UHP's HemoStrip® with metal detectable fabric for the food industry that can be easily detected if the strip were to fall off during processing or
Mar 17, 2016 11:59 am ET
United Health Products Inc. Announces Total Resources International as Specialty - Retail Distributor
United Health Products, Inc. (OTCQB: UEEC) announced that it has entered into a 5 year contract with Total Resources International (TRI) as a United States Specialty and Retail Distributor. The contract guarantees minimum purchases of United Health Products Inc.'s HemoStyp® products with yearly increases over the previous year. The contract calls for 150,000 trauma pads, 500,000 boxes of HemoStrips® and an exclusive distribution of UHP's HemoStrip® with metal detectable fabric for the food industry that can be easily detected if the strip were to fall off during processing or
Mar 09, 2016 08:30 am ET
United Health Products Inc. Announces Exclusive Distributor for India
United Health Products Inc. (OTCQB: UEEC) announced that it has entered into an exclusive distribution contract with CJ Global Capital LLC for India. The exclusive contract has a licensing fee and minimum yearly purchase requirements to maintain the rights to exclusivity to India for all of United Health Products Inc. HemoStyp® products. India's current health care industry is estimated to be USD 120 Billion and reach USD 230 Billion by 2020, with USD 5.5 Billion in Wound Care. Indian Government Expenditure on health care is the highest amongst all the developing countries. The expenses

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.